ing the dose of bronchodilator drug which reaches the bronchi. This problem was not of course resolved by the use of IPPV, which merely ensured that about the same volume of aerosol was delivered to the bronchi whatever drug or concentration was used. It is probable, however, that the average dose of isoprenaline received by the patients in this particular study was relatively large, because the increase in heart rate (29 per minute) produced by a 0.5°/,, concentration given for three minutes by IPPV was much greater than that produced by 1,000 ug. of isoprenaline administered by pressurized dispenser (13 per minute) in a previous study reported by Choo-Kang et al. (1969) on a similar group of patients. The average dose of salbutamol received by the patients must have been equally large when a 0-50/0 concentration was used, but it caused a much smaller increase in heart rate.
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IPPV has the capability, which a pressurized dispenser lacks, of delivering an adequate dose of bronchodilator aerosol to dyspnoeic patients. Such patients are often unable to inhale more than a small proportion of a single dose of aerosol from a pressurized dispenser, and this may partly account for the poor response of patients with status asthmaticus to bronchodilator drugs administered in that way. Furthermore, when the technique of IPPV is used, the drug is administered in a high concentration (40 0/% or more) of oxygen, and if the studies in experimental animals with isoprenaline reported by Collins et al. (1969) are applicable to man this may reduce considerably the potential cardiotoxic hazards associated with the use of bronchodilator aerosols.
Though it cannot, of course, be assumed that a concentration of salbutamol which does not produce tachycardia is ipso facto less likely to provoke more serious cardiac side effects, it would seem reasonable, when powerful bronchodilatation is required, to select a form of treatment which does not increase the heart rate, and which at the same time ensures adequate oxygenation. These requirements can substantially be met by the administration of a 0.5 % aerosol of salbutamol by IPPV in 40% oxygen for a period of three minutes.
Suppression of Ventricular Tachyarrhythmias by Transvenous Intracardiac
Pacing after Acute Myocardial Infarction 
Methods
All nine patients were admitted to the hospital's coronary care unit. Before developing ventricular tachyarrhythmia they showed no evidence of cardiac failure, sinus bradycardia, or atrioventricular block; however, radiographic evidence of pulmonary oedema had developed in all nine at the time pacing was begun. The patients had not received a digitalis preparation and had normal serum electrolytes. Over 10 episodes of cardiac arrest were experienced by each patient (Table I) term "cardiac arrest" is used here to indicate impairment of consciousness secondary to ventricular tachyarrhythmia which did not spontaneously revert to sinus rhythm.
After the initial episode of arrest the patients received prophylactic lignocaine by continuous infusion; additional chemotherapy was given if this failed to suppress ventricular ectopic activity (Table II) . All episodes of prolonged ventricular tachycardia or ventricular fibrillation were terminated by D.C. shock. Pacing was started when drug therapy was considered to have failed; lack of definition of this failure point resulted in a variable delay before pacing. A transvenous bipolar catheter (6F U.S.C.I.) and a fixed-rate pacemaker (Medical Electronics and Instruments, Birmingham) were used. The catheter was introduced into a medial arm vein at (Figs. 1-3) . In eight suppression occurred after an artificial increase in heart rate above the sinus rate (Table III) result,'9 thereby increasing the possibility of multiple ectopic foci, whose combined asynchronous discharge may cause ventricular fibrillation. Irregular repolarization and premature ectopic activity of the ischaemic dog ventricle have been shown, however, to disappear with an artificial increase in heart rate.'0 If myocardial infarction in man causes similar irregular repolarization which results in ventricular ectopic activity, then an artificial increase in heart rate may achieve its antiarrhythmic effect by creating regular repolarization. Ventricular ectopic activity was avoided in one patient by ventricular pacing at a similar rate to the sinus rate after more rapid atrial pacing had failed. The generation of ventricular ectopic activity in this patient may have been related to the creation of decremental block and its resultant re-entry circuits in the ischaemic His-Purkinje tissue.2 An alteration in the impulse pathway may have avoided the initiation of such block and therefore its arrhythmic consequences.
The exact time to introduce this form of therapy must be arbitrary. More It is not clear what contribution the various organs make to the total serum acid phosphatase and in particular to the tartrate-labile fraction. It has generally been assumed that the prostate is the major source of the normal serum tartratelabile acid phosphatase; hence this fraction has commonly been referred to as the "prostatic acid phosphatase." King and Jegatheesan (1959) , however, noted that the mean values of the tartrate-labile acid phosphatase are practically the same for males and females, and concluded that this "prostatic" component in normal persons must come from sites other than the prostate. It was felt that a study of a series of patients undergoing total cystoprostatectomy might shed further light on the extent to which the prostate contributes to the normal serum acid phosphatase levels. 
Patients and Methods
Total serum acid phosphatase and tartrate-labile acid phosphatase levels were determined in 100 patients. Of these, 25 were men who had total cystoprostatectomy for bladder cancer, and in 12 of these the determinations were made both before and after surgery. A detailed histological examination of the excised specimen showed that none of these patients had malignancy of the prostate. There were 25 men with no symptoms of prostatic disease, and a further 25 men who had estimations before transurethral or retropubic prostatectomy for what was subsequently shown histologically to be benign prostatic hypertrophy. Finally, determinations were made on 25 women-9 were healthy volunteers and 16 were women admitted for minor endoscopic procedures. There was no history, past or present, of carcinoma of the breast in any of these women.
Throughout, the King-Armstrong (1934) method as modified by Gutman and Gutman (1940) was used, and all results are expressed as King-Armstrong units per 100 ml. of
